[1]
Chatzigrigoriadis, C. et al. 2025. An Adverse Double-Hit by Pembrolizumab: A Case Report of Bullous Pemphigoid and Pneumonitis. Journal of Medical Cases. 16, 2 (Mar. 2025), 69–76. DOI:https://doi.org/10.14740/jmc5089.